Ocular Therapeutix Inc. buy Royal Bank of Canada
Start price
18.03.25
/
50%
€6.81
Target price
18.03.26
€15.58
Performance (%)
-14.31%
Price
18.02.26
€5.83
Summary
This prediction is currently active. The prediction for Ocular Therapeutix Inc. disappoints with a performance of -14.31%. This prediction currently runs until 18.03.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | -24.450% | -24.450% |
| iShares Core DAX® | 1.066% | -0.525% |
| iShares Nasdaq 100 | -0.493% | -4.055% |
| iShares Nikkei 225® | -2.028% | 6.911% |
| iShares S&P 500 | -0.103% | -2.366% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Ocular Therapeutix Inc.
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€8.21
05.02.26
05.02.26
-
05.02.27
05.02.27
-28.94%
18.02.26
18.02.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.41
05.11.25
05.11.25
-
05.11.26
05.11.26
-37.98%
18.02.26
18.02.26